MedPath
HSA Approval

SALBUAIR CFC-FREE INHALER 100 mcg/dose

SIN12458P

SALBUAIR CFC-FREE INHALER 100 mcg/dose

SALBUAIR CFC-FREE INHALER 100 mcg/dose

October 30, 2003

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence HolderTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

AEROSOL, SPRAY

RESPIRATORY (INHALATION)

Medical Information

R03AC02

salbutamol

Manufacturer Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

LABORATORIO ALDO-UNION S.L.

Active Ingredients

SALBUTAMOL SULPHATE

100 mcg/dose

Salbutamol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SALBUAIR CFC-FREE INHALER 100 mcg/dose - HSA Approval | MedPath